Washington Health Institute ( Site 5689) — Washington D.C., District of Columbia

Public research footprint of Washington Health Institute ( Site 5689), compiled from the ClinicalTrials.gov public registry.

Registered studies

Active

Recruiting now

Completed

Stopped or withdrawn

Most-studied conditions

HIV-1-infection · HIV · HIV/AIDS · Human Immuno-deficiency Virus (HIV) Disease

Recently updated registry entries

NCT07001319 — Study of GS-3242 in Participants With HIV-1; Substudy-05 (Completed)
NCT07300839 — A Study to Learn About a COVID-19 Vaccine in Healthy Adults 50 Through 64 Years of Age (Active Not Recruiting)
NCT04150068 — Study to Evaluate the Safety and Efficacy of Lenacapavir (GS-6207) in Combination With an… (Active Not Recruiting)

7 more recent registry entries at this facility

Enter your work email to view the full list.

I’d also like to receive occasional marketing emails from Eichor for research sites (optional — unsubscribe anytime).

Work at Washington Health Institute ( Site 5689)?

Verify and correct how your facility appears in public registry records — free.

Verify this profile →

Compiled from public registry records (ClinicalTrials.gov) as of August 03, 2026. Counts reflect how this facility appears in registry listings; name variants may exist and are not combined. This page describes public records only and makes no assessment of any facility.